[Stenosis of the trunk of left coronary artery: state-of-the-art].
Coronary artery bypass grafting (CABG) is traditionally considered to be the "golden standards" of treatment for patients with the affected trunk of left coronary artery (LCA) due to its good early and late outcome, low mortality rate and frequency of repeat surgery. This fact is well documented as reflected in relevant guidelines of European and American scientific societies. However, the recent years have witnessed markedly extended application of drug-coated stents despite the fact that immediate and delayed results of such treatment need more comprehensive verification. This review is focused on the evaluation of advisability of using drug-coated stents to manage lesioned LCA based on the results of randomized studies in comparison with CABG and percutaneous transluminal coronary angioplasty. An optimal method for the treatment of the affected LCA trunk is proposed based on the available data. It is concluded that CABG remains the method of choice for the treatment of this pathology (in the absence of contraindications) ensuring good early and late outcome, low mortality rate and necessity of repeat surgery.